When diagnosed with prostate cancer, men with limited life expectancy are being overtreated, according to a study published Nov. 11 in JAMA Internal Medicine. Researchers from Los Angeles-based Cedars ...

About 1 in 8 men will get prostate cancer in their lifetime. But a new study concludes an increasing number of men with limited life expectancy are being overtreated for the disease with procedures ...

Please provide your email address to receive an email when new articles are posted on . Many men with lower life expectancy and localized prostate cancer get overtreated. Rates of definitive treatment ...

Clinicians must appropriately assess life expectancy and take steps to avoid prostate cancer overtreatment. Even in the active surveillance era, overtreatment persists among men with limited life ...

Dr. William Russell specializes in radiation oncology in Baton Rouge. He graduated from the University of Mississippi School of Medicine in 1984. Russell is double-board certified in internal medicine ...

Men treated for nonmetastatic prostate cancer under current guidelines are up to 6 times less likely to die from their cancer than from other causes, according to data from a Swedish cancer registry.

Risk of death and cause of death 30 years after diagnosis as a proportion of 100 men. Grey figures indicate the proportion of men alive after 30 years, blue figures the proportion of men who died of ...

National guidelines from associations such as the National Comprehensive Cancer Network (NCCN) and the American Urological Association recommend that men with a life expectancy of less than 10 years ...

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...